News
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
14h
Zacks Investment Research on MSNBuy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 EarningsPfizer PFE will report its second-quarter 2025 earnings on Aug. 5, before market open. The Zacks Consensus Estimate for sales ...
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...
Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.
By the end of 2024, Axmed had partnered with over 20 organizations across 15 countries. It processed more than 4,200 orders, ...
In the aftermath of the 1971 Liberation War, newly sovereign Bangladesh inherited little industrial infrastructure.
Brokerage Investec downgraded Sun Pharma shares by two notches to 'sell' while Choice Equity Broking gave an 'Add' rating ...
Bristol-Myers Squibb Company beats revenue forecasts & raises 2025 guidance. Click for key BMY catalysts, risks, and outlook ...
In April 2025, the Trump administration introduced a major shift in trade policy by initially imposing a 37% tariff on Bangladeshi exports to the United States. This rate was later reduced to 35% and ...
11h
Zacks Investment Research on MSNOPK Stock Slips Following Q2 Earnings Miss, Gross Margin ExpandsOPKO Health, Inc. OPK delivered a loss per share of 19 cents in the second quarter of 2025, wider than the year-ago period’s ...
Pfizer (PFE) and BioNTech (BNTX) lose bid to appeal a High Court ruling that issued Moderna (MRNA) a COVID-19 vaccine patent ...
Aside from the MFN order, President Trump is also in the process of negotiating tariffs with countries all over the world. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results